Germany is the ideal location for pharmaceutical R&D, production, and sales of medicines. Driven by trends such as demographic change, a rise in chronic diseases and an increasing emphasis on prevention and self-medication, Europe’s biggest pharmaceutical market is growing faster than the German economy.
Germany belongs to the world’s leading clinical trials locations and - based on R&D investment and patent application levels - is the leading location for pharmaceutical innovation in Europe. Building on these competencies, many German organizations have become key contributors in the global fight against the Covid-19 pandemic.
Industry Overview - The Pharmaceutical Industry in Germany
Issue 2021/2022(PDF; 3.8 MB)